Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer’s disease

Abstract

Aβ-peptide ligands based on a cis -glycofused benzopyran structure have been fluorescently labeled using coumarine derivatives. Among the synthesized compounds, two conserved their binding ability to β-amyloid peptides, as shown by NMR experiments. Moreover, exploiting its fluorescent property, it was demonstrated that one of such compounds was able to cross an in vitro model of blood–brain barrier (BBB) and to stain Aβ‑deposits.